Phosphoprotein target for insulin and its antagonists
US6884575B2 · kind B2 · utility
13Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 2002 |
| Grant date | Apr 26, 2005 |
| Priority date | — |
| Expiry date | Jan 5, 2023 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/042
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides methods for diagnosing and treating individuals with insulin resistance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.